Financials data is unavailable for this security.
View more
Year on year MedCap AB (publ) grew revenues 42.84% from 1.11bn to 1.59bn while net income improved 46.43% from 117.60m to 172.20m.
Gross margin | 47.11% |
---|---|
Net profit margin | 12.30% |
Operating margin | 16.20% |
Return on assets | 12.46% |
---|---|
Return on equity | 20.36% |
Return on investment | 15.58% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at MedCap AB (publ) fell by 48.00m. However, the company earned 228.00m from its operations for a Cash Flow Margin of 14.36%. In addition the company used 152.30m on investing activities and also paid 119.70m in financing cash flows.
Cash flow per share | 21.70 |
---|---|
Price/Cash flow per share | 22.01 |
Book value per share | 77.50 |
---|---|
Tangible book value per share | 34.08 |
More ▼
Balance sheet in SEKView more
Current ratio | 2.39 |
---|---|
Quick ratio | 1.62 |
Total debt/total equity | 0.3198 |
---|---|
Total debt/total capital | 0.2416 |
More ▼
Growth rates in SEK
SmartText is unavailable
EPS growth(5 years) | 44.86 |
---|---|
EPS (TTM) vs TTM 1 year ago | 42.98 |